Plain-English translation of NCT07034339 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
Researchers are building a detailed 'immune map' of pancreatic cancer by collecting blood samples, tissue samples, and imaging data from 1,500 people across multiple hospitals. This study aims to understand how your immune system responds to pancreatic cancer at different stages and use that information to develop an artificial intelligence tool that can detect pancreatic cancer earlier and more accurately.
Pancreatic cancer is hard to catch early, and doctors don't fully understand why some people's immune systems can fight the cancer while others cannot. By studying the immune patterns of many patients over time, researchers hope to find new ways to diagnose the disease sooner and predict which treatments will work best.
You likely qualify if…
You likely don't qualify if…
You will be enrolled into one of three groups based on your condition: those receiving standard cancer treatment, those being followed over time, or those receiving chemotherapy before surgery. You'll have blood samples taken and imaging reviewed at different time points to track how your immune system changes. The study will follow you across your cancer journey — before, during, and after treatment — to understand how immunity influences your outcome.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China